pharma · Plaque Psoriasis · Diabetic Macular Edema
Bausch + Lomb
Bausch & Lomb Incorporated
Bausch + Lomb patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Rochester, IN
- Founded
- 1853
- Employees
- 38
- Programs
- 3
- Drugs
- 5
- Patents
- 25
Bausch + Lomb patents
25 pharmaceutical patents indexed for Bausch + Lomb. 0 expire within 24 months.
Bausch + Lomb has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 2020339710
GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF
granted -
US 2020239601
CROSSLINKED POLYMERIC NETWORK AND USE THEREOF
granted -
US 2019151500
OPHTHALMIC VISCOELASTIC COMPOSITIONS
granted -
CA 3043000
DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE
granted -
US 2016213609
OPHTHALMIC SUSPENSION COMPOSITION
granted -
US 2015038439
METHOD FOR PREPARING SUSPENSIONS OF LOW-SOLUBILITY MATERIALS
granted -
US 2014206764
Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions
granted -
US 2014142182
Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
granted -
CA 2883399
REDUCTION AU MINIMUM DE DEPOTS LIPIDIQUES BIOLOGIQUES SUR DES LENTILLES DE CONTACT
granted -
CA 2881745
COMPOSITIONS OPHTALMIQUES CONTENANT DES ACIDES GRAS OMEGA -3
granted -
WO 2013169458
COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES DE TRAITEMENT, DE CONTRÔLE, D'AMÉLIORATION, OU D'INVERSION DES TROUBLES DE LA KÉRATOCONJONCTIVITE SÈCHE
granted -
US 2013289070
Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines
granted -
WO 2013133980
DÉRIVÉS NITROXY DE STÉROÏDES DOUX
granted -
WO 2013126156
COMPOSÉS AGONISTES DE RÉCEPTEURS DE GLUCOCORTICOÏDES SÉLECTIFS DONNEURS D'OXYDE NITRIQUE ET COMPOSITIONS OPHTALMIQUES
granted -
CA 2864833
COMPOSITIONS OPHTALMIQUES COMPRENANT DES CIRES NATURELLES ALCOXYLEES
granted -
US 2013210912
Ophthalmic Pharmaceutical Compositions and Methods of Making and Using Same
granted -
EP 2624836
BEPOTASTIN-ZUSAMMENSETZUNG
granted -
CA 2852995
COMPOSITION OPHTALMIQUE QUI CONTIENT DU BROMFENAC PRESENTANT UNE BIODISPONIBILITE ACCRUE
granted -
CA 2851492
COMPOSITIONS OPHTALMIQUES EN GEL
granted -
US 2013023492
PHARMACEUTICAL COMPOSITIONS COMPRISING PLANT-BASED POLYSACCHARIDES AND USES THEREOF
granted -
CA 2838876
COMPOSITIONS ET PROCEDES DE TRAITEMENT, DE SUPPRESSION, DE REDUCTION OU D'AMELIORATION D'UNE DOULEUR INFLAMMATOIRE
granted -
US 8324171
Ophthalmic compositions containing diglycine
granted -
US 2012255544
BEPOTASTINE COMPOSITIONS
granted -
WO 2012039887
COMPOSITION ET MÉTHODE ACCÉLÉRANT LA CICATRISATION DES PLAIES
granted -
WO 2011162951
COMPOSITIONS ET PROCÉDÉS D'AMÉLIORATION DE LA RÉDUCTION D'UN MICRO-ORGANISME SPOROGÈNE
granted
Frequently asked questions
How many patents does Bausch + Lomb have?
25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Bausch + Lomb patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.